On April 16, a delegation headed by Dr. Issac Cohen (Chairman and CEO of Bionovo) paid a visit to Shanghai Institute of Materia Medica, CAS. Officers from Scientific Research Administration Department, extended warmest welcome to them and gave a comprehensive overview of the history and scientific achievements of SIMM. The Bionovo visitors expressed great interests in the research achievements and the progress at SIMM, and held a constructive discussion with Prof. Yiping Wang and Prof. Lijiang Xuan regarding the potential cooperation, and both parties have reached a primary agreement in terms of mutual cooperation.

 

Bionovo is a drug discovery and development company focused on developing safe and effective drugs for the treatment of unmet medical needs in women’s health and cancer. The mission of Bionovo is to improve the quality of women’s health and defeat life-threatening cancers.